Peter Chiba

4.1k total citations
127 papers, 3.3k citations indexed

About

Peter Chiba is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Peter Chiba has authored 127 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 66 papers in Molecular Biology and 22 papers in Infectious Diseases. Recurrent topics in Peter Chiba's work include Drug Transport and Resistance Mechanisms (68 papers), Cancer therapeutics and mechanisms (21 papers) and HIV/AIDS drug development and treatment (19 papers). Peter Chiba is often cited by papers focused on Drug Transport and Resistance Mechanisms (68 papers), Cancer therapeutics and mechanisms (21 papers) and HIV/AIDS drug development and treatment (19 papers). Peter Chiba collaborates with scholars based in Austria, Germany and United States. Peter Chiba's co-authors include Gerhard F. Ecker, Stephan Kopp, Diethart Schmid, Thomas Stockner, Karin Pleban, Ishrat Jabeen, E. Kaiser, Freya Klepsch, Tiange Cai and Yu Cai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Biochemistry.

In The Last Decade

Peter Chiba

126 papers receiving 3.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter Chiba 1.7k 1.3k 560 522 381 127 3.3k
Michael Wiese 2.2k 1.3× 1.6k 1.3× 1.0k 1.8× 809 1.5× 481 1.3× 108 3.8k
Adam B. Shapiro 2.0k 1.2× 1.7k 1.3× 578 1.0× 241 0.5× 679 1.8× 75 3.8k
Anne H. Dantzig 2.2k 1.3× 1.4k 1.1× 473 0.8× 186 0.4× 729 1.9× 62 3.5k
Jarkko Rautio 977 0.6× 2.1k 1.7× 417 0.7× 1.0k 1.9× 308 0.8× 88 5.0k
Chung‐Pu Wu 2.3k 1.4× 1.9k 1.5× 561 1.0× 218 0.4× 380 1.0× 86 3.8k
Rolf W. Sparidans 2.0k 1.2× 1.6k 1.2× 364 0.7× 191 0.4× 397 1.0× 169 4.2k
Ilza Pajeva 993 0.6× 1.1k 0.8× 381 0.7× 368 0.7× 172 0.5× 83 2.2k
Peter W. Swaan 2.2k 1.3× 2.9k 2.3× 363 0.6× 631 1.2× 792 2.1× 129 6.9k
Suneet Shukla 3.4k 2.0× 2.3k 1.9× 902 1.6× 321 0.6× 728 1.9× 77 5.1k
Zsolt Bikádi 932 0.5× 1.7k 1.3× 179 0.3× 589 1.1× 207 0.5× 70 3.1k

Countries citing papers authored by Peter Chiba

Since Specialization
Citations

This map shows the geographic impact of Peter Chiba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Chiba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Chiba more than expected).

Fields of papers citing papers by Peter Chiba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Chiba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Chiba. The network helps show where Peter Chiba may publish in the future.

Co-authorship network of co-authors of Peter Chiba

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Chiba. A scholar is included among the top collaborators of Peter Chiba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Chiba. Peter Chiba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Ying, Tao Cai, Richard Callaghan, et al.. (2019). Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells. SHILAP Revista de lepidopterología. 1 indexed citations
2.
Huang, Qingqing, Tiange Cai, Li Bai, et al.. (2019). State of the art of overcoming efflux transporter mediated multidrug resistance of breast cancer. Translational Cancer Research. 8(1). 319–329. 5 indexed citations
3.
Fuchs, Claudia, G. Paumgartner, Annika Wahlström, et al.. (2016). Metabolic preconditioning protects BSEP/ABCB11−/− mice against cholestatic liver injury. Journal of Hepatology. 66(1). 95–101. 54 indexed citations
4.
Bauer, Florian F., Thomas Wanek, Severin Mairinger, et al.. (2012). Interaction of HM30181 with P-glycoprotein at the murine blood–brain barrier assessed with positron emission tomography. European Journal of Pharmacology. 696(1-3). 18–27. 9 indexed citations
5.
Schmid, Diethart, et al.. (2011). An abundant, truncated human sulfonylurea receptor 1 splice variant has prodiabetic properties and impairs sulfonylurea action. Cellular and Molecular Life Sciences. 69(1). 129–148. 9 indexed citations
6.
Klepsch, Freya, Ishrat Jabeen, Peter Chiba, & Gerhard F. Ecker. (2010). Pharmacoinformatic Approaches to Design Natural Product Type Ligands of ABC-Transporters. Current Pharmaceutical Design. 16(15). 1742–1752. 15 indexed citations
7.
8.
Schmid, Diethart, et al.. (2009). Pinacidil-primed ATP-sensitive potassium channels mediate feedback control of mechanical power output in isolated myocardium of rats and guinea pigs. European Journal of Pharmacology. 628(1-3). 116–127. 2 indexed citations
9.
Perruchon, Johann, Regina Ortmann, Hans‐Martin Dahse, et al.. (2009). Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone. Bioorganic & Medicinal Chemistry. 17(22). 7690–7697. 10 indexed citations
10.
Ecker, Gerhard F., Thomas Stockner, & Peter Chiba. (2008). Computational models for prediction of interactions with ABC-transporters. Drug Discovery Today. 13(7-8). 311–317. 45 indexed citations
11.
Heffeter, Petra, Michael A. Jakupec, Wilfried Körner, et al.. (2007). Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24). Biochemical Pharmacology. 73(12). 1873–1886. 85 indexed citations
12.
Thriemer, Kamala, et al.. (2007). Characterization of a novel class of antimalarials and its applicability to plasmodial target identification. Wiener klinische Wochenschrift. 119(S3). 83–87. 1 indexed citations
13.
Ecker, Gerhard F., Karin Pleban, Stephan Kopp, et al.. (2004). A Three-Dimensional Model for the Substrate Binding Domain of the Multidrug ATP Binding Cassette Transporter LmrA. Molecular Pharmacology. 66(5). 1169–1179. 18 indexed citations
14.
Ecker, Gerhard F., Edina Csaszar, Stephan Kopp, et al.. (2002). Identification of Ligand-Binding Regions of P-Glycoprotein by Activated-Pharmacophore Photoaffinity Labeling and Matrix-Assisted Laser Desorption/Ionization–Time-of-Flight Mass Spectrometry. Molecular Pharmacology. 61(3). 637–648. 4 indexed citations
15.
Ecker, Gerhard F., et al.. (1999). The Importance of a Nitrogen Atom in Modulators of Multidrug Resistance. Molecular Pharmacology. 56(4). 791–796. 107 indexed citations
16.
Chiba, Peter, et al.. (1999). Artificial Neural Networks as Versatile Tools for Prediction of MDR-Modulatory Activity. Advances in experimental medicine and biology. 457. 95–105. 1 indexed citations
17.
Chiba, Peter, et al.. (1998). Synthesis and pharmacological activity of the stereoisomers of GP-88, a propafenone-type modulator of multidrug resistance. Bioorganic & Medicinal Chemistry Letters. 8(7). 829–832. 11 indexed citations
18.
Chiba, Peter, Gerhard F. Ecker, Diethart Schmid, et al.. (1996). Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance.. Molecular Pharmacology. 49(6). 1122–1130. 79 indexed citations
19.
Pillwein, Konrad, et al.. (1993). Cytotoxicity, differentiating activity and metabolism of tiazofurin in human neuroblastoma cells. International Journal of Cancer. 55(1). 92–95. 11 indexed citations
20.
Chiba, Peter, et al.. (1988). S-Adenosylmethionine metabolism in HL-60 cells: effect of cell cycle and differentiation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 971(1). 38–45. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Wiese Breakdown of academic impact, for papers by Adam B. Shapiro Breakdown of academic impact, for papers by Anne H. Dantzig Breakdown of academic impact, for papers by Jarkko Rautio Breakdown of academic impact, for papers by Chung‐Pu Wu Breakdown of academic impact, for papers by Rolf W. Sparidans Breakdown of academic impact, for papers by Ilza Pajeva Breakdown of academic impact, for papers by Peter W. Swaan Breakdown of academic impact, for papers by Suneet Shukla Breakdown of academic impact, for papers by Zsolt Bikádi
Rankless by CCL
2026